Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,973 | -14,479 | -8,044 | -41,873 | -31,755 |
| Depreciation Amortization | 469 | 413 | 67 | -144 | -195 |
| Accounts receivable | N/A | N/A | N/A | -84 | -955 |
| Accounts payable and accrued liabilities | -864 | -810 | 410 | 525 | 985 |
| Other Working Capital | -2,913 | -2,600 | -1,295 | 1,651 | 467 |
| Other Operating Activity | 2,938 | 2,228 | 403 | 3,869 | 3,203 |
| Operating Cash Flow | $-20,343 | $-15,248 | $-8,459 | $-36,056 | $-28,250 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,000 | 2,000 | 2,000 | 28,310 | 21,310 |
| PPE Investments | -52 | 1 | 1 | -84 | -84 |
| Investing Cash Flow | $1,948 | $2,001 | $2,001 | $28,226 | $21,226 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,726 | 1,726 | N/A | N/A | N/A |
| Common Stock Issued | 24,538 | 19,783 | 19,783 | 2,480 | 621 |
| Common Stock Repurchased | -1,303 | -1,193 | N/A | N/A | -13 |
| Other Financing Activity | -1,333 | -1,333 | -2,068 | -2,410 | -1,333 |
| Financing Cash Flow | $23,628 | $18,983 | $17,715 | $70 | $-725 |
| Beginning Cash Position | 24,846 | 24,846 | 24,846 | 32,606 | 32,606 |
| End Cash Position | 30,079 | 30,582 | 36,103 | 24,846 | 24,857 |
| Net Cash Flow | $5,233 | $5,736 | $11,257 | $-7,760 | $-7,749 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,343 | -15,248 | -8,459 | -36,056 | -28,250 |
| Capital Expenditure | -53 | N/A | N/A | -84 | -84 |
| Free Cash Flow | -20,396 | -15,248 | -8,459 | -36,140 | -28,334 |